ClinicalTrials.Veeva

Menu

Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

Fudan University logo

Fudan University

Status

Unknown

Conditions

Carcinoma, Non-Small-Cell Lung

Treatments

Procedure: sublobar resection
Procedure: lobectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03108560
ZSTS201701

Details and patient eligibility

About

The incidence rate of ground-glass opacity (GGO) has been increasing these years. A great number of retrospective studies suggested that sublobar resection was better for some GGO patients. However, no prospective clinical study supports the perspective. This study is prospective, multi-center, randomized-controlled. The aim of this study is to investigate whether sublobar resection is inferior to lobectomy for cT1N0M0 non-small-cell lung cancer or not.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cT1N0M0 non-small-cell lung cancer
  • ground-glass opacity, ≤2cm, GGO≥25%
  • eligible for both lobectomy and sublobar resection
  • intraoperative pathology is minimally-invasive adenocarcinoma or invasive adenocarcinoma
  • intraoperative pathology of biopsied station 10 lymph node is negative

Exclusion criteria

  • intraoperative pathology is benign nodule, atypical adenomatous hyperplasia, or adenocarcinoma in-situ
  • intraoperative pathology of biopsied station 10 lymph node is positive
  • multiple GGOs, lesions other than dominant lesion are malignant or >5mm
  • history of thoracic surgery
  • history of malignancy in recent 5 years
  • unstable systemic disease
  • patients with psychiatric disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

600 participants in 2 patient groups

Sublobar group
Experimental group
Description:
Patients receive sublobar resection, including wedge resection and segmentectomy.
Treatment:
Procedure: sublobar resection
Lobectomy group
Active Comparator group
Description:
Patients receive lobectomy.
Treatment:
Procedure: lobectomy

Trial contacts and locations

1

Loading...

Central trial contact

Junjie Xi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems